Evaluation of Problems with Tuberculosis in the Czech Republic in 2002;Hodnocení Situace Tuberkulózy v České Republice v Roce 2002

Casopis Lekaru Ceskych

Volumn 142, Issue 12, 2003, Pages 746-750

  Krejbich, František ^a,c   Trnka, L ^a   Mazankova V ^b  

^a Klinika Pneumologie a TBC   (Czech Republic)

^b Institute of Health Information and Statistics of the Czech Republic   (Czech Republic)

^c UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

Author keywords

Incidence of tuberculosis; Resistance; TB case; TB treatment; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CZECH REPUBLIC; DISEASE CONTROL; DRUG RESISTANCE; FEMALE; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; RELAPSE; TREATMENT FAILURE; TREATMENT PLANNING; TUBERCULOSIS;

EID: 0346732238     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. WHO: WHO Report 2003, Global Tuberculosis Control, Surveillance, Planning, Financing, WHO/CDS/TB/2003.316,WHO/CDS/TB/2003.316.
2. WHO: Global Tuberculosis Programme: Treatment of tuberculosis, Guidelines for National Programmes, Third Edition 2003, WHO, Geneva, Switzerland, WHO/CDC/TB/2003.313.
3. WHO: Global Tuberculosis Programme: Treatment of tuberculosis, Guidelines for National Programmes, Second Edition. 1997, WHO, Geneva, Switzerland, WHO/CDC/TB/97.220.
4. Instrukce č. 1/1986 Ministerstva zdravotnictvi ČSR, Federálního ministerstva národní obrany ČSR, Federálního ministerstva vnitra ČSR a Ministerstva spravedlnosti ČSR o klasifikaci tuberkulózy a jinych mykobakterióz a o poskytování dispenzární péče v oboru tuberkulózy a respiračnich nemocí, Věstník vlády ČSR pro národní výbory v částce 1 z roku 1986.
5. EuroTB (INVS/KNCV) and national coordinators for tuberculosis surveillance in the WHO European Region: Surveillance of tuberculosis in Europe. Report on tuberculosis cases in Europe.
6. Treatment of tuberculosis. Guidelines for national programmes. WHO, Geneva 1997, s. 1-77.
7. Veen, J., Raviglione, M. C., Rieder, H. L.: Standardised treatment outcome monitoring in Europe. Recomendation of WHO and IUATLD Working Group. Third European Workshop on Tuberculosis Control in Low Prevalence Countries, Noordwijk, Netherlands, 15-20 June 1997. Eur. Respir. J., 12, 1998, s. 1-54.
8. WHO, Regional Office for Europe: Strategy to Control Tuberculosis in the WHO European Region, Copenhagen 2000, s. 1-54.
9. Miller, B., Rosenbaum, S., Stange, P. V. et al.: Tuberculosis Control in a Changing Health care Systém: Model Contract Specifications for Managed Care Organizations. Clin. Inf. Dis., 27, 1998, s. 677-686.
10. Trnka, L., Daňková, D., Krejbich, F.: Is quarterly cohort analysis useful for assassing treatment outcomes in a low incidence country? Int. J. Tuerc. Lung Dis., 5, 2001, s. 250-256.
11. Davidson, B. L.: A controlled comparison of directly observed therapy vs self-administrated therapy for active tuberculosis in the urban United States. Chest, 114, 1998, s. 1239-1243.
12. Zellweger, J. P., Coulon, P.: Outcome of patients treated for tuberculosis in Vaud Country, Switzerland, Int. J. Tuberc. Lung. Dis., 2, 1998, s. 372-377.